Shopping Cart
Total:

$0.00

Items:

0

Your cart is empty
Keep Shopping

Quality-of-Life Outcomes Underreported in GU Cancer Trials



(MedPage Today) — SAN FRANCISCO — Despite a growing emphasis on quality-of-life (QoL) endpoints and patient-reported outcomes in cancer trials, the reporting of those results has been inconsistent for prostate, kidney, and bladder cancer trials…



Source link

0
Show Comments (0) Hide Comments (0)
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments